Atlas Trials

Stereotactic Radiation and Nivolumab in the Management of Metastatic Breast Cancer Brain Metastases

Clinical trial NCT03807765 · COMPLETED

Trial details

NCT number
NCT03807765
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic Breast CancerBrain Metastases
Start date
2019-01-30
Primary completion
2020-09-08
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.